EUVIMEDEUVIMED entdecken
Crossref

Investigation of the role of ILC2 in middle ear mucosa using a novel model of eosinophilic otitis media

Daisuke Matsushita, Naomi Kudo, Satoshi Suzuki, Tomoaki Fujita, Kei Matsushita, Junko Takahata, Atsushi Matsubara

Auris Nasus Larynx · 2026

DOI: 10.1016/j.anl.2026.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Auris Nasus Larynx, 2026. Verfasst von Daisuke Matsushita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Hirosaki University Hospital, Hirosaki, Japan. Hauptthemen laut MEDLINE: Eosinophilia, Eosinophils, Ear, Middle, Otitis Media. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Eosinophilic otitis media (EOM) is considered a type 2 inflammation of the middle ear mucosa. In this study, we investigated the role of type 2 innate lymphoid cells (ILC2s) in EOM using a novel animal model locally stimulated with a plant protease Papain. METHODS: Hartley Guinea pigs were injected with 25 μg of Papain into the tympanic cavity daily for 12 days. Eosinophil infiltration and mucin production in the middle ear mucosa were examined histologically, and the localization of ILC2s was investigated using immunohistochemical methods. RESULTS: In the Papain-stimulated group, a significantly larger number of eosinophils were observed in the middle ear mucosa, and mucin enriched with eosinophils was observed around the tympanic ostium of the Eustachian tube. The number of ILC2s in the middle ear mucosa of the stimulated group significantly increased compared to the control group. CONCLUSION: This is the first report on Papain-induced allergic disease models in the middle ear. In the stimulated group, hyperproduction of mucin containing eosinophils in the tympanic cavity and increased ILC2s in the mucosa were observed. The novel model presented in this study may contribute to the elucidation of the pathogenesis of EOM as a type 2 inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EosinophiliaEosinophilsEar, MiddleOtitis MediaMucous MembraneLymphocytesAnimalsGuinea PigsDisease Models, AnimalPapainMucinsImmunity, InnateEustachian TubeInterleukin-13Immunohistochemistry

Stichwörter der Autor:innen

Eosinophilic otitis mediaIL-13ILC2MucinPapain

Substanzen

PapainMucinsInterleukin-13

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Hirosaki University Hospital, Hirosaki, Japan.
  • Hirosaki University Graduate School of Medicine, Otorhinolaryngology-Head and Neck Surgery, Hirosaki, Japan. Electronic address: knaomi@hirosaki-u.ac.jp.
  • Hirosaki University Graduate School of Medicine, Otorhinolaryngology-Head and Neck Surgery, Hirosaki, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Matsushita, D., Kudo, N., Suzuki, S., Fujita, T., Matsushita, K., Takahata, J., & Matsubara, A. (2026). Investigation of the role of ILC2 in middle ear mucosa using a novel model of eosinophilic otitis media. Auris Nasus Larynx. https://doi.org/10.1016/j.anl.2026.02.005

Vancouver

Matsushita D, Kudo N, Suzuki S, Fujita T, Matsushita K, Takahata J, et al. Investigation of the role of ILC2 in middle ear mucosa using a novel model of eosinophilic otitis media. Auris Nasus Larynx. 2026. doi:10.1016/j.anl.2026.02.005

BibTeX
@article{Matsushita2026,
  author = {Matsushita, Daisuke and Kudo, Naomi and Suzuki, Satoshi and Fujita, Tomoaki and Matsushita, Kei and Takahata, Junko and Matsubara, Atsushi},
  title = {Investigation of the role of ILC2 in middle ear mucosa using a novel model of eosinophilic otitis media},
  journal = {Auris Nasus Larynx},
  year = {2026},
  doi = {10.1016/j.anl.2026.02.005}
}
Kostenlos starten →